| Anand Subramony Eli Lilly, Indianapolis, USA |
Mano Manoharan Alnylam Pharmaceuticals |
S. G. Srivatsan IISER Pune, Pune, India |
| Anil Kore Convergence Bio, Boston USA |
Martin Egli Vanderbilt University, Nashville, USA |
Sudhir Agarwal Arnay Sciences, Boston, USA |
| Annemieke Aartsma-Rus Serepta Therapeutics, Cambridge, USA |
Martin Maier Alnylam Pharmaceuticals, Boston, USA |
Surajit Sinha IACS, Kolkata, India |
| Beatriz Llamusí Troísi ARTHEx Biotech, Valencia, Spain |
Masad Damha McGill University, Montreal, Canada |
Takeshi Wada Wave Life Sciences, Boston, USA |
| Chandra Vargeese Wave Life Sciences, Boston, USA |
Meena Stoke therapeutics, Cambridge, MA, USA |
Thazha Prakash Ionis Pharma, Carlsbad, USA |
| David Corey UT Southwestern Medical Centre, Dallas Texas, USA |
Poulami Talukder Tiba Biotech, Boston, USA |
Thomas Carell LMU, Munchen, Germany |
| Ishu Sarogi IISER Bhopal, Bhopal, India |
P. I. Pradeepkumar IIT Bombay, Mumbai, India |
Vasant Jadhav Alnylam Therapeutics, Boston, USA |
| Jaya Goyal Novo Nordisk, Boston, USA |
Rajeev Kallanthottathil Verve Therapeutics, Boston, USA |
Venkat Krishnamurthy Korrobiochem, Boston, USA |
| Jyotirmoyee Dash IACS, Kolkata, India |
Ramon Eritja IQAC-CSIC, Barcelona, Spain |
Yogesh Sanghvi Rasayan, Encinitas, CA, USA |
| Mangala Sounder PepGen, Boston, USA |
Sritama Bose Nucleic Acid Therapy Accelerator, Harwell, UK |